Some Features Of Sensorineural Hearing Loss In Neurological Practice
Keywords:
sensorineural hearing loss, neuroprotectors, biomarkersAbstract
This study presents scientific results on certain aspects of sensorineural hearing loss in neurological practice. Modern research indicates that sensorineural hearing loss is associated with oxidative stress, microcirculation disorders, and inflammatory processes. The introduction of new diagnostic methods, such as molecular genetics, neurodegeneration biomarkers, and imaging techniques, has improved early diagnosis and disease prognosis. Thus, for the treatment of sensorineural hearing loss occurring in neurological diseases, modern therapeutic strategies include the use of neuroprotectors, antioxidants, gene therapy, and cellular regeneration of the auditory nerve
References
Neurological update: neuro-otology 2023. Journal of Neurology, 2023.
Sensorineural hearing loss. MedLink Neurology, 2023.
Gene therapy for hearing loss: challenges and the promise of cellular reprogramming. Frontiers
in Neurology, 2024.
Stem cell therapy in sensorineural hearing loss: a systematic review. The Egyptian Journal of
Otolaryngology, 2023.
Inflammatory markers and the risk of idiopathic sudden sensorineural hearing loss. Frontiers in
Neurology, 2023
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.
